What is the treatment for an infant diagnosed with hip dysplasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Infant Hip Dysplasia

For infants diagnosed with hip dysplasia, the Pavlik harness is the first-line treatment for those under 6 months of age, with 70-95% success rates when initiated early, ideally before 7 weeks of age. 1, 2, 3

Age-Based Treatment Algorithm

Birth to 6 Months: Pavlik Harness Protocol

The Pavlik harness should be applied as soon as DDH is confirmed in infants with unstable hips or significant dysplasia on ultrasound, maintaining the hip in >90° flexion with 45-50° abduction to achieve concentric reduction while avoiding avascular necrosis. 2, 4, 5

  • Treatment is most effective when started before 6 weeks of age, with efficacy decreasing as age increases 1
  • The harness can be used up to 6 months of age with overall success rates of 67-83% 1
  • Continue treatment until the hip is stable and shows concentric reduction on imaging 2, 5

Monitoring During Harness Treatment

Ultrasound is the preferred modality for monitoring harness treatment, performed to confirm concentric hip reduction, assess treatment response, and identify early signs of failure. 1

  • Predictors of harness failure include: low post-reduction alpha angle, <20% femoral head coverage, femoral nerve palsy, irreducible hips, initiation after 7 weeks, right hip dislocation, Graf Type IV hips, and male sex 1, 3
  • If stable reduction cannot be obtained after 2 weeks of Pavlik harness treatment, alternative treatment is indicated 4

When Conservative Treatment Fails

If the Pavlik harness fails after 2 weeks or the hip remains irreducible, proceed to examination under general anesthesia with possible closed reduction. 4, 3

  • Closed reduction is indicated after failed bracing 3
  • If concentric reduction cannot be obtained with closed methods, open surgical reduction is the next step 4, 6

Special Considerations by Hip Classification

Graf Type IIa (Immature Hip)

  • No treatment required for infants <3 months with alpha angle 50-59°, as 60-90% resolve spontaneously 1, 2
  • Follow-up imaging is advised due to small risk of delayed displacement or acetabular dysplasia 1

Graf Type IIb, IIc, IId, III, and IV

  • All require immediate referral for treatment with Pavlik harness 1
  • Type III (low displacement) and Type IV (high displacement) hips require immediate treatment 1

Critical Pitfalls to Avoid

The most serious complication of treatment is avascular necrosis of the femoral head, which occurs with overtreatment or excessive abduction beyond 50°. 1, 2

  • Universal ultrasound screening leads to overdiagnosis and unnecessary treatment, increasing iatrogenic AVN risk 1
  • Do not perform ultrasound before 2 weeks of age due to high false-positive rates from physiologic laxity 2, 7
  • Avoid treating Graf Type IIa hips in infants <3 months, as most normalize spontaneously 1, 2

Age-Specific Treatment Transitions

Infants diagnosed after 6 months often require surgical correction rather than harness treatment, as the ability to stand and progressive soft-tissue contractures preclude harness use. 1, 4, 5

  • Children aged 12-18 months requiring open reduction face longer recovery, with walking typically resuming 4-6 months after cast removal 8
  • Late diagnosis is a major negative prognostic factor, requiring more complex treatment and increasing risk of long-term complications 1

Long-Term Outcomes

Early diagnosis and treatment with Pavlik harness demonstrates very good therapeutic success with low rates of residual dysplasia (2.81%) and excellent clinical outcomes at 20+ year follow-up. 9

  • Unrecognized and untreated DDH inevitably leads to early degenerative joint disease, causing up to one-third of total hip arthroplasties in patients <60 years 1
  • Serial physical examinations should continue at all well-child visits through age 5, with follow-up radiographs at ages 1 and 4 years to assess acetabular development and detect AVN 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Developmental Dysplasia of the Hip Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Development dysplasia of the hip from birth to six months.

The Journal of the American Academy of Orthopaedic Surgeons, 2000

Research

Developmental hip dysplasia and dislocation: Part II.

Instructional course lectures, 2004

Guideline

Indications for Hip Ultrasound in 1-2 Month Old Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Walking Timeline After Hip Dysplasia Surgery Before 18 Months

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the management options for congenital dysplasia, including hip dysplasia and fibrous dysplasia?
What physical exam tests and investigations should be done for a 5-month-old infant with asymmetrical hip creases to confirm developmental dysplasia of the hip (DDH)?
What are the characteristics of Developmental Dysplasia of the Hip (DDH) in newborns?
What is the recommended management for a 12-month-old child with asymmetrical hip crease, steep acetabulum roofs, and increased acetabular angles?
What is the treatment for congenital dysplasia, including hip dysplasia?
What should I do if I think I have a muscle tear in my abdomen, considering my age, medical history, and physical activity level?
What dose of Anti-D (Rho(D) immune globulin) should be administered to an RhD negative mother who received Anti-D at 24 weeks of gestation and has delivered an RhD positive baby?
What is the best approach to manage severe anxiety in a patient with a history of poor tolerance to venlafaxine, currently taking sertraline, lamotrigine, guanfacine, and clonazepam?
Does a chest computed tomography (CT) scan require contrast agent administration for a typical adult patient with no known kidney disease or allergies?
What is the best course of treatment for a patient with microcytic anemia, indicated by a low Mean Corpuscular Volume (MCV) and high Red Cell Distribution Width (RDW), and potentially complicated by underlying chronic diseases?
What is the best course of action for an elderly patient with hypertension (high blood pressure), currently taking amlodipine (calcium channel blocker) 5 mg, with a blood pressure reading of 160/77 mmHg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.